Portfolio of Genomics Stocks
Genomics includes agrigenomics, bacterial genomics, bioinformatics, cancer genomics, diagnostics, drug discovery, equipment, pharmacogenomics and research.
Here is a table of 11 genomics stocks.
|11 Genomics Stocks|
Stock Returns & Price Chart
Recent Prices &
|Price data from Quandl as of most recent close.|
To inspect the performance of the Genomics Stocks portfolio, see the chart below. Portfolio values are computed using monthly closes for stocks from Quandl.The 7 stocks included in the portfolio computations are: A, ALNY, EXAS, ILMN, MYGN, QGEN and SGMO. The current value of the portfolio assumes that $1,428.57 was invested (total of $10,000) in each stock at its closing monthly price for the first date shown on the portfolio value chart below. All prices are adjusted for splits and dividends. The 4 stocks excluded from the portfolio computations because of insufficient price data are: CRSP, EDIT, IONS and ONCE.
The current value of a $10,000 investment is $106,628. The percent return is 966.28%. The annualized return is 26.70%.
|Return Summary for Genomics Stocks|
|Current Value of Investment||$106,627.60|
|Number Profitable Returns||6,606|
|Percent Profitable Returns||90.99%|
|Number Unprofitable Returns||654|
|Percent Unprofitable Returns||9.01%|
|Profitable to Unprofitable Returns Ratio||10.10|
NOTE: The stocks included in the tables and chart are representative of the industry. They are not recommendations.